IRIS
FERRAU', Oscar
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 578
EU - Europa 454
AS - Asia 138
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.172
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 575
IE - Irlanda 132
SE - Svezia 108
CN - Cina 87
UA - Ucraina 54
GB - Regno Unito 49
DE - Germania 44
SG - Singapore 39
FI - Finlandia 29
IT - Italia 22
BE - Belgio 14
IN - India 10
CA - Canada 3
CL - Cile 1
ES - Italia 1
EU - Europa 1
IR - Iran 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 1.172
Salva come PNG Salva come JPEG
Città #
Dublin 132
Jacksonville 118
Chandler 108
Nyköping 65
Ann Arbor 52
Ashburn 45
Beijing 42
Lancaster 37
Singapore 33
Cambridge 19
Medford 19
Princeton 19
Des Moines 18
Brussels 14
Woodbridge 14
Salerno 12
Boardman 10
Dearborn 10
Los Angeles 10
Munich 9
Pune 8
Espoo 6
Jinan 6
Haikou 5
Auburn Hills 4
Hangzhou 4
Helsinki 4
San Mateo 4
Ottawa 3
Washington 3
Changsha 2
Chicago 2
Guangzhou 2
Kunming 2
Messina 2
Taizhou 2
Zhengzhou 2
Ardabil 1
Chongqing 1
Fuzhou 1
Ganzhou 1
Hanover 1
Hefei 1
Hyderabad 1
Lanzhou 1
Leawood 1
Milan 1
Mountain View 1
Nanchang 1
Nanjing 1
Ningbo 1
Norwalk 1
Palermo 1
Phoenix 1
Saint Louis 1
San Francisco 1
Seattle 1
Shanghai 1
Shenyang 1
Taiyuan 1
Tianjin 1
Wilmington 1
Xingtai 1
Totale 873
Salva come PNG Salva come JPEG
Nome #
High serum resistin in chronic viral hepatitis is not a marker of metabolic disorder. 93
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma 89
Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: Effect of treatment with recombinant alpha interferon 83
TOPICAL TREATMENT OF DISTAL ACTIVE ULCERATIVE COLITIS WITH BECLOMETHASONE DIPROPIONATE OR MESALAZINE 79
Serum thrombopoietin in chronic liver disease: Relation to severity of the disease and spleen size 79
Efficacy of interferon treatment (IFN) in elderly patients with chronic hepatitis C 66
Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma? 65
FOCAL LYMPHOCYTIC AGGREGATES IN CHRONIC HEPATITIS-C - OCCURRENCE, IMMUNOHISTOCHEMICAL CHARACTERIZATION, AND RELATION TO MARKERS OF AUTOIMMUNITY 58
Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up 58
Studio comparativo dgeli effetti della bromopride e della metoclopramide sulla funzione ipotalamo-ipofisaria. 58
Ten year follow-up of patients with chronic hepatitis C treated with interferon 56
HCV INFECTION, HEPATIC HLA DISPLAY AND COMPOSITION OF THE MONONUCLEAR CELL INFLAMMATORY INFILTRATE IN CHRONIC-ALCOHOLIC LIVER-DISEASE 54
Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits. 53
Tamoxifen in the treatment of Hepatocellular Carcinoma: 5-year results of the CLIP-1 multicentre randomized controlled trial 52
Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study. 51
High circulating D-dimers are associated with ascites and hepatocellularcarcinoma in liver cirrhosis. 51
Clinical Outcome of HBeAg-Negative Chronic Hepatitis B in Relation to Virological Response to Lamivudine 48
Effect of Potassium Canrenoate, an Anti-aldosterone Agent, on Incidence ofAscites and Variceal Progression in Cirrhosis. 46
Soluble CD30 serum levels before and after treatment with alpha-interferon in patients with chronic hepatitis 41
Totale 1.180
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.864
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020121 0 0 0 0 0 12 25 17 3 34 29 1
2020/2021130 19 2 31 6 3 20 2 17 2 12 10 6
2021/2022140 3 26 5 5 5 2 7 3 2 21 22 39
2022/2023404 26 44 27 24 37 34 2 34 160 3 10 3
2023/202496 7 14 4 9 6 33 0 15 0 2 0 6
2024/202577 4 10 7 46 0 10 0 0 0 0 0 0
Totale 1.180